FDA Inspection 1023320 — Fziomed Inc
The FDA completed an inspection of Fziomed Inc on August 17, 2017 in San Luis Obispo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 17, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Luis Obispo, CA (United States)